Free Trial

Amphastar Pharmaceuticals (AMPH) News Today

$40.45
+0.67 (+1.68%)
(As of 06/21/2024 08:59 PM ET)
Stethoscope on a stock chart
Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts
Will the market get interest rate cuts at all this year? That is the question that looms over most investors' shoulders today.
Stethoscope on a stock chart
Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts
These 2 small cap healthcare stocks could boom on a new sector breakout, Wall Street analysts see up to double-digit upside in each
Amphastar Pharmaceuticals logo with Medical background
Boone Capital Management LLC Makes New $24.74 Million Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Boone Capital Management LLC bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 400,000 shares of the company'
Amphastar Pharmaceuticals logo with Medical background
Floyd F. Petersen Sells 3,000 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 3,000 shares of the firm's stock in a transaction on Monday, June 10th. The shares were sold at an average price of $41.40, for a total value of $124,200.00. Following the completion of the sale, the director now owns 78,409 shares in the company, valued at $3,246,132.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Amphastar Pharmaceuticals logo with Medical background
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Epoch Investment Partners Inc.
Epoch Investment Partners Inc. lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 348.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 592,530 shares of the company's stock af
Amphastar Pharmaceuticals logo with Medical background
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Floyd F. Petersen Sells 500 Shares
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) Director Floyd F. Petersen sold 500 shares of the business's stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $42.65, for a total transaction of $21,325.00. Following the completion of the sale, the director now owns 78,333 shares in the company, valued at $3,340,902.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Amphastar Pharmaceuticals logo with Medical background
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by US Bancorp DE
US Bancorp DE boosted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 2,648.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,248 shares of the company's stock after purchas
Amphastar Pharmaceuticals logo with Medical background
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Update
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 3,770,000 shares, a drop of 5.5% from the April 30th total of 3,990,000 shares. Based on an average trading volume of 410,500 shares, the short-interest ratio is currently 9.2 days. Currently, 10.7% of the shares of the company are sold short.
Amphastar Pharmaceuticals logo with Medical background
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by TD Asset Management Inc
TD Asset Management Inc boosted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 449.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 793,559 shares of the company's stoc
Amphastar Pharmaceuticals logo with Medical background
Capital One Financial Analysts Boost Earnings Estimates for Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) - Capital One Financial increased their Q2 2024 earnings per share estimates for Amphastar Pharmaceuticals in a research note issued on Wednesday, May 22nd. Capital One Financial analyst T. Chiang now expects that the company will post e
Amphastar Pharmaceuticals logo with Medical background
Trexquant Investment LP Buys Shares of 38,959 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Trexquant Investment LP bought a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 38,959 shares of the com
Amphastar Pharmaceuticals logo with Medical background
Charles Schwab Investment Management Inc. Increases Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Charles Schwab Investment Management Inc. lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 379,480 shares of the company's stock af
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP reduced its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 29.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,339,142 shares of the company's stock a
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Up 4.6%
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading 4.6% Higher
Amphastar Pharmaceuticals' (AMPH) Hold Rating Reaffirmed at Needham & Company LLC
Needham & Company LLC reaffirmed a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Wednesday.
BNP Paribas Financial Markets Cuts Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
BNP Paribas Financial Markets lowered its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 20.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,806 shares of the company's stock after se
Reassessing Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. reduced its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 63,667 shares of the company's stock a
Mesirow Institutional Investment Management Inc. Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Mesirow Institutional Investment Management Inc. raised its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 37.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 252,8
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Up to $42.21
Amphastar Pharmaceuticals (NASDAQ:AMPH) Receives Hold Rating from Needham & Company LLC
Needham & Company LLC restated a "hold" rating on shares of Amphastar Pharmaceuticals in a report on Thursday.
Amphastar: Q1 Earnings Snapshot
LSV Asset Management Has $19.64 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
LSV Asset Management boosted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 49.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 317,600 shares of the company's stock aft
Amphastar Pharmaceuticals (AMPH) Scheduled to Post Quarterly Earnings on Wednesday
Amphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=418090)
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Increase in Short Interest
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 3,870,000 shares, a growth of 5.4% from the March 31st total of 3,670,000 shares. Based on an average daily volume of 430,500 shares, the short-interest ratio is currently 9.0 days. Approximately 11.0% of the company's stock are sold short.
Get Amphastar Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter.

$25,000 into $109,616 in two months? (Ad)

Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…

Go here to watch the most recent trading workshop video at no charge.

AMPH Media Mentions By Week

AMPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMPH
News Sentiment

0.50

0.69

Average
Medical
News Sentiment

AMPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMPH Articles
This Week

2

4

AMPH Articles
Average Week

Get Amphastar Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AMPH) was last updated on 6/24/2024 by MarketBeat.com Staff

From Our Partners